Bank of Nova Scotia’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.48M | Sell |
17,225
-25,652
| -60% | -$2.25M | ﹤0.01% | 826 |
|
|
2026
Q1 | $3.88M | Buy |
42,877
+11,876
| +38% | +$1.09M | 0.01% | 631 |
|
|
2025
Q4 | $2.79M | Buy |
31,001
+6,639
| +27% | +$630K | ﹤0.01% | 736 |
|
|
2025
Q3 | $2.4M | Buy |
24,362
+3,677
| +18% | +$364K | ﹤0.01% | 677 |
|
|
2025
Q2 | $1.89M | Sell |
20,685
-89,099
| -81% | -$8.62M | ﹤0.01% | 691 |
|
|
2025
Q1 | $12.4M | Sell |
109,784
-100,703
| -48% | -$10.8M | 0.03% | 329 |
|
|
2024
Q4 | $22.2M | Buy |
210,487
+184,327
| +705% | +$19.8M | 0.04% | 273 |
|
|
2024
Q3 | $2.82M | Sell |
26,160
-91,093
| -78% | -$9.94M | 0.01% | 583 |
|
|
2024
Q2 | $12.7M | Buy |
117,253
+28,763
| +33% | +$3.39M | 0.02% | 330 |
|
|
2024
Q1 | $11.7M | Sell |
88,490
-46,239
| -34% | -$5.78M | 0.02% | 375 |
|
|
2023
Q4 | $16.4M | Buy |
134,729
+112,237
| +499% | +$12.5M | 0.03% | 325 |
|
|
2023
Q3 | $2.52M | Sell |
22,492
-37,394
| -62% | -$4.75M | 0.01% | 531 |
|
|
2023
Q2 | $8.72M | Buy |
59,886
+41,964
| +234% | +$5.7M | 0.02% | 302 |
|
|
2023
Q1 | $2.32M | Sell |
17,922
-75,153
| -81% | -$9.44M | 0.01% | 509 |
|
|
2022
Q4 | $11.9M | Buy |
93,075
+72,328
| +349% | +$8.39M | 0.03% | 322 |
|
|
2022
Q3 | $2.17M | Buy |
20,747
+3,504
| +20% | +$385K | 0.01% | 613 |
|
|
2022
Q2 | $1.81M | Sell |
17,243
-8,708
| -34% | -$1.03M | ﹤0.01% | 712 |
|
|
2022
Q1 | $3.32M | Sell |
25,951
-17,799
| -41% | -$2.15M | 0.01% | 694 |
|
|
2021
Q4 | $5.4M | Buy |
43,750
+5,763
| +15% | +$754K | 0.01% | 675 |
|
|
2021
Q3 | $5.4M | Sell |
37,987
-19,556
| -34% | -$2.88M | 0.01% | 618 |
|
|
2021
Q2 | $8.98M | Sell |
57,543
-13,483
| -19% | -$2.18M | 0.02% | 471 |
|
|
2021
Q1 | $11M | Buy |
71,026
+40,395
| +132% | +$6.26M | 0.02% | 380 |
|
|
2020
Q4 | $4.58M | Sell |
30,631
-11,930
| -28% | -$1.68M | 0.01% | 531 |
|
|
2020
Q3 | $5.63M | Buy |
42,561
+920
| +2% | +$120K | 0.02% | 448 |
|
|
2020
Q2 | $4.83M | Buy |
41,641
+35,757
| +608% | +$4.12M | 0.02% | 420 |
|
|
2020
Q1 | $577K | Buy |
5,884
+18
| +0.3% | +$2.36K | ﹤0.01% | 747 |
|
|
2019
Q4 | $852K | Buy |
5,866
+108
| +2% | +$14.9K | ﹤0.01% | 762 |
|
|
2019
Q3 | $767K | Sell |
5,758
-64,398
| -92% | -$8.32M | ﹤0.01% | 772 |
|
|
2019
Q2 | $8.02M | Buy |
70,156
+4,317
| +7% | +$506K | 0.03% | 330 |
|
|
2019
Q1 | $8.16M | Buy |
65,839
+1,925
| +3% | +$219K | 0.03% | 342 |
|
|
2018
Q4 | $6.44M | Buy |
63,914
+21,419
| +50% | +$2.41M | 0.03% | 348 |
|
|
2018
Q3 | $5.42M | Buy |
42,495
+19,523
| +85% | +$2.32M | 0.02% | 413 |
|
|
2018
Q2 | $2.49M | Sell |
22,972
-3,654
| -14% | -$398K | 0.01% | 454 |
|
|
2018
Q1 | $2.82M | Sell |
26,626
-6,112
| -19% | -$710K | 0.01% | 491 |
|
|
2017
Q4 | $3.83M | Sell |
32,738
-3,403
| -9% | -$385K | 0.02% | 455 |
|
|
2017
Q3 | $4.11M | Sell |
36,141
-10,705
| -23% | -$1.24M | 0.02% | 412 |
|
|
2017
Q2 | $5.84M | Sell |
46,846
-530
| -1% | -$62.8K | 0.03% | 401 |
|
|
2017
Q1 | $5.62M | Buy |
47,376
+42,794
| +934% | +$4.85M | 0.02% | 398 |
|
|
2016
Q4 | $459K | Buy |
4,582
+412
| +10% | +$44.2K | ﹤0.01% | 623 |
|
|
2016
Q3 | $526K | Buy |
4,170
+494
| +13% | +$61K | ﹤0.01% | 512 |
|
|
2016
Q2 | $430K | Buy |
3,676
+227
| +7% | +$25.7K | ﹤0.01% | 524 |
|
|
2016
Q1 | $357K | Buy |
3,449
+185
| +6% | +$17.9K | ﹤0.01% | 549 |
|
|
2015
Q4 | $325K | Hold |
3,264
| – | – | ﹤0.01% | 588 |
|
|
2015
Q3 | $298K | Buy |
3,264
+103
| +3% | +$10.3K | ﹤0.01% | 539 |
|
|
2015
Q2 | $335K | Buy |
3,161
+77
| +2% | +$8.52K | ﹤0.01% | 454 |
|
|
2015
Q1 | $352K | Buy |
3,084
+216
| +8% | +$24.6K | ﹤0.01% | 438 |
|
|
2014
Q4 | $316K | Buy |
2,868
+93
| +3% | +$9.8K | ﹤0.01% | 454 |
|
|
2014
Q3 | $271K | Buy |
2,775
+59
| +2% | +$5.8K | ﹤0.01% | 470 |
|
|
2014
Q2 | $274K | Sell |
2,716
-143
| -5% | -$14K | ﹤0.01% | 462 |
|
|
2014
Q1 | $262K | Buy |
2,859
+167
| +6% | +$15.4K | ﹤0.01% | 490 |
|
|
2013
Q4 | $244K | Buy |
2,692
+54
| +2% | +$4.67K | ﹤0.01% | 503 |
|
|
2013
Q3 | $210K | Sell |
2,638
-142
| -5% | -$11.2K | ﹤0.01% | 492 |
|
|
2013
Q2 | $201K | Buy |
+2,780
| New | +$208K | ﹤0.01% | 477 |
|
Other funds holding ZBH
Bank of Nova Scotia's ZBH Position: Q2 2026 in Review
Bank of Nova Scotia reduced its Zimmer Biomet (ZBH) stake by 60% in Q2 2026, selling an estimated $2.25M and leaving 17,225 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #826.
Bank of Nova Scotia first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $22.2M in Q4 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Bank of Nova Scotia held 17,225 shares of Zimmer Biomet worth $1.48M as of Q2 2026.
- Bank of Nova Scotia sold 25,652 Zimmer Biomet shares in Q2 2026, an estimated $2.25M.
- Zimmer Biomet made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q2 2026, its #826 holding.
- Bank of Nova Scotia first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Bank of Nova Scotia's Zimmer Biomet position peaked at $22.2M in Q4 2024.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.